Medical Xpress August 25, 2025
The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose monitoring system for weight management.
Signos integrates the Stelo by Dexcom glucose biosensor with an artificial intelligence-driven platform to show how food, activity, stress, sleep, and timing affect the body in real time—empowering people to make personalized, biology-backed health decisions.
Key features of the monitoring system include personalized metabolic guidance that uses the body’s own signals and artificial intelligence-driven insights to help users improve sleep, manage weight, and lower chronic disease risk. The system translates real-time glucose fluctuations into simple, personalized recommendations for healthier daily habits and tracks and connects responses to meals, exercise, sleep, and stress.
Customers can subscribe to Signos with a...
Today's Sponsors
Today's Sponsor